2. Academic Validation
  3. Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody

Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody

  • J Cancer Res Clin Oncol. 2023 Oct 7. doi: 10.1007/s00432-023-05433-3.
Yan Wang 1,  Xianqin Song 1,  Yu Song 1,  Kehua Fang 2,  Xiaotian Chang 3
Affiliations

Affiliations

  • 1 Medical Research Center of The Affiliated Hospital of Qingdao University, Wutaishan Road 1677, Qingdao, 266000, Shandong, People's Republic of China.
  • 2 Clinical Laboratory of The Affiliated Hospital of Qingdao University, Wutaishan Road 1677, Qingdao, 266000, Shandong, People's Republic of China. [email protected].
  • 3 Medical Research Center of The Affiliated Hospital of Qingdao University, Wutaishan Road 1677, Qingdao, 266000, Shandong, People's Republic of China. [email protected].
PMID: 37804426 DOI: 10.1007/s00432-023-05433-3
Abstract

Background: Peptidyl arginine deiminase 4 (PADI4) is a post-translational modification enzymecan that converts arginine in protein into citrulline in the presence of calcium ions, which is called citrullination. PADI4 has been reported to be expressed in the cytoplasm and nucleus in a variety of malignant tumors. Based on the GeneCards database and our previous research, it is speculated that PADI4 may also be expressed on the cell membrane. This study aimed to confirm the membrane expression of PADI4 and the effect of anti-PADI4 Antibodies on cell membrane PADI4. This may be another mechanism of action of anti-PADI4 monoclonal Antibodies in the treatment of breast Cancer.

Methods: The subcellular localizations of PADI4 in MDA-MB-231 and MCF-7 breast Cancer cells were determined by immunofluorescence, immunoelectron microscopy, and Western blot analysis. The tumor cells were treated with PADI4 antibody, and cell proliferation, migration, colony formation, Apoptosis, glycolysis, and epithelial-mesenchymal transition (EMT) were measured as well as the expression of some essential tumor genes.

Results: PADI4 was not only localized in the nucleus and cytoplasm of breast Cancer cells but was also detected on the cell membrane. Following PADI4 antibody treatment, cell proliferation, migration, colony formation, EMT, and ATP production through glycolysis were decreased, and the mRNA expression of MYC proto-oncogene (MYC), FAT atypical cadherin 1 (FAT1), nuclear factor kappa B subunit 1 (NFκB), and tumor necrosis factor (TNF-α) in breast Cancer cells was downregulated, while the mRNA expression of tumor protein p63 (TP63) was upregulated.

Conclusions: PADI4 is expressed on the cell membrane in breast Cancer cells. Anti-PADI4 Antibodies can affect the biological functions of cell membrane PADI4, including proliferation, migration, Apoptosis, and glycolysis, thereby inhibiting tumor progression.

Keywords

Breast cancer; Membrane expression; Molecular therapy; PADI4.

Figures
Products